Global Footprint Emmes operates across the US, Europe, Canada, and India, enabling end-to-end global trial execution and regulatory support for sponsors expanding into multiple geographies.

Disease Expertise Specialization in vaccines and infectious diseases with pandemic research capability positions Emmes to accelerate vaccine and infectious disease programs with compliant, scalable operations.

Data-Driven Capabilities Investments in data management platforms, biostatistics, and bioinformatics deliver robust analytics, adaptive trial design support, and rapid data delivery to inform decision-making.

Collaborative Scale A mid-market CRO with 1000+ professionals and extensive trial experience offers scalable, agile program management and flexible engagement models suitable for sponsors seeking quality and speed.

Therapeutic Breadth Broad therapeutic expertise including ophthalmology, immunology, neuroscience, and cell and gene therapy creates cross-sell opportunities across trial phases and service lines.